Cargando…

Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases

PURPOSE: The purpose of this study was to investigate the effect of 21-gene recurrence score (RS) on predicting prognosis and chemotherapy decision in node micrometastases (N1mi) breast invasive ductal carcinoma (IDC). METHODS: Patients with stage T1-2N1mi and estrogen receptor-positive IDC diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-Rong, Deng, Jia-Peng, Wang, Jun, Sun, Jia-Yuan, He, Zhen-Yu, Wu, San-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790862/ https://www.ncbi.nlm.nih.gov/pubmed/30913871 http://dx.doi.org/10.4143/crt.2018.611

Ejemplares similares

Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component
por: Zeng, Yufei, et al.
Publicado: (2020)

Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer
por: Wu, San-Gang, et al.
Publicado: (2019)

Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis
por: Zhou, Ping, et al.
Publicado: (2020)

Cytological Correlates of Axillary Nodal Involvement in Invasive Ductal Carcinoma of Breast
por: Sinha, Anamika, et al.
Publicado: (2019)

Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis
por: Wu, San-Gang, et al.
Publicado: (2018)

21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes
por: Tong, Yiwei, et al.
Publicado: (2019)

Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis
por: Deng, Xu Feng, et al.
Publicado: (2016)

The immunocytochemical detection of axillary micrometastases in breast cancer.
por: Wells, C. A., et al.
Publicado: (1984)

Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?
por: Yu, Jing, et al.
Publicado: (2020)

The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes
por: Wang, Jun, et al.
Publicado: (2018)

21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
por: Wu, San-Gang, et al.
Publicado: (2019)

Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast
por: Hasebe, T, et al.
Publicado: (2005)

Micrometastases in sentinel nodes of gastric cancer
por: Ajisaka, H, et al.
Publicado: (2003)

Micrometastases in axillary nodes: Out of the reckoning?
por: Singh, Akshita, et al.
Publicado: (2016)

Prognostic significance of further axillary dissection in breast cancer patients with micrometastases & the number of micrometastases: a SEER population-based analysis
por: Ying-Ying, Liu, et al.
Publicado: (2018)

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
por: Osako, Tomo, et al.
Publicado: (2014)

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay
por: Osako, T, et al.
Publicado: (2012)

The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis
por: Makower, Della, et al.
Publicado: (2022)

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
por: Hasebe, T, et al.
Publicado: (2011)

Association of One-Step Nucleic Acid Amplification Detected Micrometastases with Tumour Biology and Adjuvant Chemotherapy
por: Goussous, Ghaleb, et al.
Publicado: (2017)

Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21-gene recurrence score of 26–30
por: Yu, Jing, et al.
Publicado: (2020)

Nodal staging score and adequacy of nodal staging
por: Chen, Hui-Min, et al.
Publicado: (2019)

Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy
por: Wu, San-Gang, et al.
Publicado: (2013)

Identification of novel drugs to target dormant micrometastases
por: Hurst, Robert E., et al.
Publicado: (2015)

MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
por: Zhou, Zhuxian, et al.
Publicado: (2015)

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.
por: Trojani, M., et al.
Publicado: (1987)

Does surgery modify growth kinetics of breast cancer micrometastases?
por: Demicheli, R, et al.
Publicado: (2001)

21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer
por: Zhang, Wen-Wen, et al.
Publicado: (2019)

Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma
por: Behring, Michael, et al.
Publicado: (2018)

Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score
por: Gao, Weiqi, et al.
Publicado: (2020)

The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study
por: Abel, Mary Kathryn, et al.
Publicado: (2022)

Radioimmunotherapy of micrometastases in lung with vascular targeted(213)Bi
por: Kennel, S J, et al.
Publicado: (1999)

Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
por: Kerboeuf, Mikael, et al.
Publicado: (2021)

Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases
por: Qutaish, Mohammed Q., et al.
Publicado: (2018)

A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy
por: Li, Yuqiang, et al.
Publicado: (2021)

Bone marrow micrometastases in early breast cancer–30-year outcome
por: Mansi, J, et al.
Publicado: (2016)

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome
por: Naume, B, et al.
Publicado: (2005)

The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
por: Wu, San-Gang, et al.
Publicado: (2020)

Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast
por: Lee, Jung Ah, et al.
Publicado: (2011)

A tumour spheroid model for antibody-targeted therapy of micrometastases.
por: Walker, K. A., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_uvt9if5ft6ggrku0f5g0d83ds2